A first: Drug lowers heart risks by curbing inflammation People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. Doctors say the results on the drug open a new frontier. Results were published Sunday by the New England Journal of Medicine and Lancet. Published 6:17 AM ET Sun, 27 Aug 2017
Read this whole article and see how Anatabine Citrate could be even more effective and safer than this MAB drug:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.